L&C Bio posted an operating profit of 8.58 billion won ($6.06 million) on a consolidated basis in the second quarter, swinging to a profit from a loss a year earlier, the company disclosed Tuesday.
Revenue for the same period rose 88.4 percent to 38.78 billion won.
The net loss for the quarter widened from the year-earlier period to 28.12 billion won, according to a preliminary tally.
jiyoon436@heraldcorp.com
